Stay updated with breaking news from Roche Ocrevus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TG Therapeutics Inc said on Wednesday that the U.S. health regulator had approved its monoclonal antibody for treating patients with relapsing forms of multiple sclerosis, sending its shares up... | December 28, 2022
(Reuters) - The U.S. health regulator on Wednesday approved TG Therapeutics Inc's drug for patients with relapsing forms of multiple sclerosis, pittin...
/PRNewswire/ -- Following an eventful 2021 that included the launch of two new brands—Novartis' Kesimpta and BMS' Zeposia—and generic versions of Biogen's...
/PRNewswire/ -- Spherix Global Insights, a leading market intelligence firm specializing in neurology-based research and insights, has been tracking the...
